Efanesoctocog alfa offers sustained prophylaxis in severe hemophilia A: Interim analysis of the XTEND-ed LTE study

Early initiation of luspatercept derives greater benefit in ESA-naive TD LR-MDS: Post-hoc analysis of the phase 3 COMMANDS trial

Ponatinib + blinatumomab vs. imatinib + chemotherapy in newly diagnosed adult Ph+ ALL: First results from the GIMEMA ALL2820 trial

Post-HSCT gilteritinib resumption improves OS in R/R FLT3mut+ AML: Pooled analysis of the phase 3 ADMIRAL and COMMODORE trials

Improved survival outcomes observed with non-TBI-based conditioning in NGS-MRD-negative B-ALL undergoing allogeneic HCT

IV iron use during acute infections associated with lower mortality in IDA